Qi-Yu Chen1,2, Xu-Hui Li1,2,3, Jing-Shan Lu1,2, Yinglu Liu1,3, Jung-Hyun Alex Lee3, Yu-Xin Chen1, Wantong Shi1, Kexin Fan1, Min Zhuo4,5,6. 1. Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. 2. International Institute for Brain Research, Qingdao International Academician Park, Qingdao, China. 3. Department of Physiology, University of Toronto, 1 King's College Circle, Toronto, ON, Canada. 4. Center for Neuron and Disease, Frontier Institutes of Science and Technology, Xi'an Jiaotong University, Xi'an, China. min.zhuo@utoronto.ca. 5. International Institute for Brain Research, Qingdao International Academician Park, Qingdao, China. min.zhuo@utoronto.ca. 6. Department of Physiology, University of Toronto, 1 King's College Circle, Toronto, ON, Canada. min.zhuo@utoronto.ca.
Abstract
INTRODUCTION: N-Methyl-D-aspartate receptors (NMDARs) play a critical role in different forms of plasticity in the central nervous system. NMDARs are always assembled in tetrameric form, in which two GluN1 subunits and two GluN2 and/or GluN3 subunits combine together. Previous studies focused mainly on the hippocampus. The anterior cingulate cortex (ACC) is a key cortical region for sensory and emotional functions. NMDAR GluN2A and GluN2B subunits have been previously investigated, however much less is known about the GluN2C/2D subunits. RESULTS: In the present study, we found that the GluN2C/2D subunits are expressed in the pyramidal cells of ACC of adult mice. Application of a selective antagonist of GluN2C/2D, (2R*,3S*)-1-(9-bromophenanthrene-3-carbonyl) piperazine-2,3-dicarboxylic acid (UBP145), significantly reduced NMDAR-mediated currents, while synaptically evoked EPSCs were not affected. UBP145 affected neither the postsynaptic long-term potentiation (post-LTP) nor the presynaptic LTP (pre-LTP). Furthermore, the long-term depression (LTD) was also not affected by UBP145. Finally, both UBP145 decreased the frequency of the miniature EPSCs (mEPSCs) while the amplitude remained intact, suggesting that the GluN2C/2D may be involved in presynaptic regulation of spontaneous glutamate release. CONCLUSIONS: Our results provide direct evidence that the GluN2C/2D contributes to evoked NMDAR mediated currents and mEPSCs in the ACC, which may have significant physiological implications.
INTRODUCTION: N-Methyl-D-aspartate receptors (NMDARs) play a critical role in different forms of plasticity in the central nervous system. NMDARs are always assembled in tetrameric form, in which two GluN1 subunits and two GluN2 and/or GluN3 subunits combine together. Previous studies focused mainly on the hippocampus. The anterior cingulate cortex (ACC) is a key cortical region for sensory and emotional functions. NMDAR GluN2A and GluN2B subunits have been previously investigated, however much less is known about the GluN2C/2D subunits. RESULTS: In the present study, we found that the GluN2C/2D subunits are expressed in the pyramidal cells of ACC of adult mice. Application of a selective antagonist of GluN2C/2D, (2R*,3S*)-1-(9-bromophenanthrene-3-carbonyl) piperazine-2,3-dicarboxylic acid (UBP145), significantly reduced NMDAR-mediated currents, while synaptically evoked EPSCs were not affected. UBP145 affected neither the postsynaptic long-term potentiation (post-LTP) nor the presynaptic LTP (pre-LTP). Furthermore, the long-term depression (LTD) was also not affected by UBP145. Finally, both UBP145 decreased the frequency of the miniature EPSCs (mEPSCs) while the amplitude remained intact, suggesting that the GluN2C/2D may be involved in presynaptic regulation of spontaneous glutamate release. CONCLUSIONS: Our results provide direct evidence that the GluN2C/2D contributes to evoked NMDAR mediated currents and mEPSCs in the ACC, which may have significant physiological implications.
Authors: Praseeda Mullasseril; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Hongjie Yuan; Natalie L Kurtkaya; Rose Santangelo; Anna G Orr; Phuong Le; Kimberly M Vellano; Dennis C Liotta; Stephen F Traynelis Journal: Nat Commun Date: 2010-10-05 Impact factor: 14.919
Authors: C R Scherzer; G B Landwehrmeyer; J A Kerner; T J Counihan; C M Kosinski; D G Standaert; L P Daggett; G Veliçelebi; J B Penney; A B Young Journal: J Comp Neurol Date: 1998-01-05 Impact factor: 3.215
Authors: Rylan S Larsen; Rebekah J Corlew; Maile A Henson; Adam C Roberts; Masayoshi Mishina; Masahiko Watanabe; Stuart A Lipton; Nobuki Nakanishi; Isabel Pérez-Otaño; Richard J Weinberg; Benjamin D Philpot Journal: Nat Neurosci Date: 2011-02-06 Impact factor: 24.884
Authors: S Akbarian; N J Sucher; D Bradley; A Tafazzoli; D Trinh; W P Hetrick; S G Potkin; C A Sandman; W E Bunney; E G Jones Journal: J Neurosci Date: 1996-01 Impact factor: 6.167
Authors: Jonathan Garst-Orozco; Ruchi Malik; Thomas A Lanz; Mark L Weber; Hualin Xi; Dominique Arion; John F Enwright; David A Lewis; Patricio O'Donnell; Vikaas S Sohal; Derek L Buhl Journal: PLoS One Date: 2020-06-04 Impact factor: 3.240
Authors: Alen V Eapen; Diego Fernández-Fernández; John Georgiou; Zuner A Bortolotto; Stafford Lightman; David E Jane; Arturas Volianskis; Graham L Collingridge Journal: Neuropharmacology Date: 2021-10-09 Impact factor: 5.250